Evidence map›Paper›PMID 35344544›Full record

ReviewPLoS neglected tropical diseases2022

Whole genome sequence analysis of Salmonella Typhi in Papua New Guinea reveals an established population of genotype 2.1.7 sensitive to antimicrobials.

Zoe Anne Dyson, Elisheba Malau, Paul F Horwood, Rebecca Ford, Valentine Siba, Mition Yoannes, William Pomat, Megan Passey, Louise M Judd, Danielle J Ingle and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Genome sequence ofMicrobiology resource announcements · 2026
    Article
  3. Comparative genomics ofVirulence · 2025
    Article
  4. Genetic heterogeneity in theMicrobial genomics · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Zoe Anne DysonLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0002-8887-3492
Elisheba MalauSchool of Science, Psychology and Sport, Federation University, Churchill, Australia.
Paul F HorwoodCollege of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia.ORCID 0000-0001-9622-0742
Rebecca FordPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Valentine SibaPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.ORCID 0000-0003-1113-2407
Mition YoannesPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
William PomatPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Megan PasseyUniversity Centre for Rural Health, Faculty of Medicine and Health, University of Sydney, Lismore, Australia.ORCID 0000-0001-5766-0235
Louise M JuddDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.ORCID 0000-0003-3613-4839
Danielle J IngleDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Deborah A WilliamsonDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Gordon DouganCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Andrew R GreenhillSchool of Science, Psychology and Sport, Federation University, Churchill, Australia.
Kathryn E HoltLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0003-3949-2471
Papua New Guinea Institute of Medical Research · PGFederation University · AUThe University of Melbourne · AUUniversity of Cambridge · GBJames Cook University · AULondon School of Hygiene & Tropical Medicine · GBMonash University · AUThe University of Sydney · AU

Funding

Wellcome TrustWellcome Trust 106158/Z/14/Z
6 · The paper itself

Abstract

backgroundTyphoid fever, a systemic infection caused by Salmonella enterica serovar Typhi, remains a considerable public health threat in impoverished regions within many low- and middle-income settings. However, we still lack a detailed understanding of the emergence, population structure, molecular mechanisms of antimicrobial resistance (AMR), and transmission dynamics of S. Typhi across many settings, particularly throughout the Asia-Pacific islands. Here we present a comprehensive whole genome sequence (WGS) based overview of S. Typhi populations circulating in Papua New Guinea (PNG) over 30 years. PRINCIPLE

findingsBioinformatic analysis of 86 S. Typhi isolates collected between 1980-2010 demonstrated that the population structure of PNG is dominated by a single genotype (2.1.7) that appears to have emerged in the Indonesian archipelago in the mid-twentieth century with minimal evidence of inter-country transmission. Genotypic and phenotypic data demonstrated that the PNG S. Typhi population appears to be susceptible to former first line drugs for treating typhoid fever (chloramphenicol, ampicillin and co-trimoxazole), as well as fluoroquinolones, third generation cephalosporins, and macrolides. PNG genotype 2.1.7 was genetically conserved, with very few deletions, and no evidence of plasmid or prophage acquisition. Genetic variation among this population was attributed to either single point mutations, or homologous recombination adjacent to repetitive ribosomal RNA operons. SIGNIFICANCE: Antimicrobials remain an effective option for the treatment of typhoid fever in PNG, along with other intervention strategies including improvements to water, sanitation and hygiene (WaSH) related infrastructure and potentially the introduction of Vi-conjugate vaccines. However, continued genomic surveillance is warranted to monitor for the emergence of AMR within local populations, or the introduction of AMR associated genotypes of S. Typhi in this setting.

Indexed as

Salmonella typhiTyphoid FeverAnti-Bacterial AgentsGenotypeHumansPapua New GuineaSequence AnalysisAnti-Bacterial Agents

Identifiers

PMID35344544
PMCPMC8989336
OpenAlexW4225313355

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.